Crossing barriers between primary and secondary care for pharmacists
AML immunotherapy: patients need to be well informed
Transplantation today: what are the key messages
ABL001 – a new BCR-ABL inhibitor for chronic myeloid leukemia (CML) treatment
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?